Press Releases

Vascular Grafts Market is Anticipated to Grow US$ 3.8 Bn By 2030

Share This Article

The global Vascular Grafts market size is expected to reach USD 3.8 billion by 2030 and is expected to expand at a CAGR of 9.8% from 2021 to 2030.

Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/38538

Growth Factors

 The increasing prevalence of various cardiovascular disorders, such as Myocardial Infarction (MI), Coronary Heart Disease (CHD) or Coronary Artery Disease (CAD), and stroke, coupled with rising demand for minimally invasive surgeries among the patient population is boosting the market growth. Increasing customer spending power, supportive reimbursement policies associated with vascular surgeries, and a surge in the demand for technologically advanced products are expected to offer numerous growth opportunities during the forecast period. The growth of the segment is due to the increasing prevalence of cardiovascular aneurysms. A sedentary lifestyle, limited physical activity, and substance abuse are resulting in a high prevalence of renal and cardiac diseases globally. The impact of these factors is especially high in developed regions such as North America and Europe.

Report Coverage

Report Scope Details
Market Size US$ 3.8 Bn by 2030
Growth Rate CAGR of 9.8% From 2021 to 2030
Base Year 2020
Historic Data 2017 to 2020
Forecast Period 2021 to 2030
Segments Covered Product, Application, Raw material
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned Medtronic plc; Terumo Corporation; LeMaitre Vascular, Inc.; Getinge AB; Cook Medical; C.R. Bard; W.L. Gore and Associates, Inc.; and Shanghai Suokang Medical Implants Co. Ltd.; Getinge AB

Report Highlights

The cardiac aneurysm segment dominated the market and held the largest revenue share of 70.7%. It can be attributed to the rising geriatric population, increasing cases of high blood pressure and high cholesterol levels, unhealthy lifestyle habits, and the adoption of advanced tissue-engineered grafts for pediatric congenital heart surgeries. The vascular occlusion segment is anticipated to register the fastest CAGR during the forecast period. Easy availability of graft procedures, especially the saphenous vein graft, and increasing prevalence of vascular occlusive diseases are factors driving the demand for these products for this application.

The polytetrafluoroethylene vascular graft segment dominated the market and held the largest revenue share of 56.5% in 2020. The segment is anticipated to register the fastest growth during the forecast period. PTFE is developed using a technologically sophisticated design that results in low blood loss and high delamination resistance. The polyester vascular grafts segment is also expected to witness significant growth during the forecast period. Easy availability of raw material, high tensile strength, and durability are key factors that attributes to its market share.

North America dominated the vascular grafts market and accounted for the largest revenue share of 40.4% in 2020. The prominent drivers of the market are increased awareness and improved health care facilities for cardiovascular treatment. MEA, the market is expected to register the fastest growth during the forecast period. The rising incidence of cardiovascular diseases, diabetes, and end-stage heart and kidney failures is expected to boost the usage rates of vascular grafts in minimally invasive procedures over the forecast period.

Key Players

  • Medtronic plc
  • Terumo Corporation
  • LeMaitre Vascular, Inc.
  • C.R. Bard; W.L. Gore and Associates, Inc.
  • Cook Medical
  • Shanghai Suokang Medical Implants Co. Ltd.
  • Getinge AB

Market Segmentation

  • Product
    • Hemodialysis Access Grafts
    • Endovascular Stent Grafts
    • Coronary Artery By-Pass Grafts
    • Vascular Grafts for Aorta Disease
    • Peripheral Vascular Grafts
  • Application
    • Cardiac Aneurysm
      • Endovascular Stent Graft
      • Vascular Graft
    • Kidney Failure
    • Vascular Occlusion
    • Coronary Artery Disease
  • Raw Material
    • Polyester Vascular Grafts
    • Polytetrafluoroethylene Vascular Grafts
    • Polyurethane Vascular Grafts
    • Biological Material Based Vascular Grafts
      • Human Saphenous and Umbilical Veins
      • Tissue Engineered Materials
  • Regional
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
    • Asia Pacific
      • Japan
      • China
      • India
      • Australia
      • Singapore
      • South Korea
    • Latin America
      • Brazil
      • Mexico
      • Argentina
    • MEA
      • South Africa
      • Saudi Arabia
      • UAE

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38538

Reasons to Purchase this Report:

– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Vascular Grafts Market, By Product

7.1.  Vascular Grafts Market, by Product, 2021-2030

7.1.1.    Hemodialysis Access Grafts

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Endovascular Stent Grafts

7.1.2.1.        Market Revenue and Forecast (2017-2030)

7.1.3.    Coronary Artery By-Pass Grafts

7.1.3.1.        Market Revenue and Forecast (2017-2030)

7.1.4.    Vascular Grafts for Aorta Disease

7.1.4.1.        Market Revenue and Forecast (2017-2030)

7.1.5.    Peripheral Vascular Grafts

7.1.5.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global Vascular Grafts Market, By Application

8.1.  Vascular Grafts Market, by Application, 2021-2030

8.1.1.    Cardiac Aneurysm

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Kidney Failure

8.1.2.1.        Market Revenue and Forecast (2017-2030)

8.1.3.    Vascular Occlusion

8.1.3.1.        Market Revenue and Forecast (2017-2030)

8.1.4.    Coronary Artery Disease

8.1.4.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global Vascular Grafts Market, By Raw Material

9.1.  Vascular Grafts Market, by Raw Material, 2021-2030

9.1.1.    Polyester Vascular Grafts

9.1.1.1.        Market Revenue and Forecast (2017-2030)

9.1.2.    Polytetrafluoroethylene Vascular Grafts

9.1.2.1.        Market Revenue and Forecast (2017-2030)

9.1.3.    Polyurethane Vascular Grafts

9.1.3.1.        Market Revenue and Forecast (2017-2030)

9.1.4.    Biological Material Based Vascular Grafts

9.1.4.1.        Market Revenue and Forecast (2017-2030)

Chapter 10.      Global Vascular Grafts Market, Regional Estimates and Trend Forecast

10.1.        North America

10.1.1.  Market Revenue and Forecast, by Product (2017-2030)

10.1.2.  Market Revenue and Forecast, by Application (2017-2030)

10.1.3.  Market Revenue and Forecast, by Raw Material (2017-2030)

10.1.4.  U.S.

10.1.4.1.      Market Revenue and Forecast, by Product (2017-2030)

10.1.4.2.      Market Revenue and Forecast, by Application (2017-2030)

10.1.4.3.      Market Revenue and Forecast, by Raw Material (2017-2030)

10.1.5.  Rest of North America

10.1.5.1.      Market Revenue and Forecast, by Product (2017-2030)

10.1.5.2.      Market Revenue and Forecast, by Application (2017-2030)

10.1.5.3.      Market Revenue and Forecast, by Raw Material (2017-2030)

10.2.        Europe

10.2.1.  Market Revenue and Forecast, by Product (2017-2030)

10.2.2.  Market Revenue and Forecast, by Application (2017-2030)

10.2.3.  Market Revenue and Forecast, by Raw Material (2017-2030)

10.2.4.  UK

10.2.4.1.      Market Revenue and Forecast, by Product (2017-2030)

10.2.4.2.      Market Revenue and Forecast, by Application (2017-2030)

10.2.4.3.      Market Revenue and Forecast, by Raw Material (2017-2030)

10.2.5.  Germany

10.2.5.1.      Market Revenue and Forecast, by Product (2017-2030)

10.2.5.2.      Market Revenue and Forecast, by Application (2017-2030)

10.2.5.3.      Market Revenue and Forecast, by Raw Material (2017-2030)

10.2.6.  France

10.2.6.1.      Market Revenue and Forecast, by Product (2017-2030)

10.2.6.2.      Market Revenue and Forecast, by Application (2017-2030)

10.2.6.3.      Market Revenue and Forecast, by Raw Material (2017-2030)

10.2.7.  Rest of Europe

10.2.7.1.      Market Revenue and Forecast, by Product (2017-2030)

10.2.7.2.      Market Revenue and Forecast, by Application (2017-2030)

10.2.7.3.      Market Revenue and Forecast, by Raw Material (2017-2030)

10.3.        APAC

10.3.1.  Market Revenue and Forecast, by Product (2017-2030)

10.3.2.  Market Revenue and Forecast, by Application (2017-2030)

10.3.3.  Market Revenue and Forecast, by Raw Material (2017-2030)

10.3.4.  India

10.3.4.1.      Market Revenue and Forecast, by Product (2017-2030)

10.3.4.2.      Market Revenue and Forecast, by Application (2017-2030)

10.3.4.3.      Market Revenue and Forecast, by Raw Material (2017-2030)

10.3.5.  China

10.3.5.1.      Market Revenue and Forecast, by Product (2017-2030)

10.3.5.2.      Market Revenue and Forecast, by Application (2017-2030)

10.3.5.3.      Market Revenue and Forecast, by Raw Material (2017-2030)

10.3.6.  Japan

10.3.6.1.      Market Revenue and Forecast, by Product (2017-2030)

10.3.6.2.      Market Revenue and Forecast, by Application (2017-2030)

10.3.6.3.      Market Revenue and Forecast, by Raw Material (2017-2030)

10.3.7.  Rest of APAC

10.3.7.1.      Market Revenue and Forecast, by Product (2017-2030)

10.3.7.2.      Market Revenue and Forecast, by Application (2017-2030)

10.3.7.3.      Market Revenue and Forecast, by Raw Material (2017-2030)

10.4.        MEA

10.4.1.  Market Revenue and Forecast, by Product (2017-2030)

10.4.2.  Market Revenue and Forecast, by Application (2017-2030)

10.4.3.  Market Revenue and Forecast, by Raw Material (2017-2030)

10.4.4.  GCC

10.4.4.1.      Market Revenue and Forecast, by Product (2017-2030)

10.4.4.2.      Market Revenue and Forecast, by Application (2017-2030)

10.4.4.3.      Market Revenue and Forecast, by Raw Material (2017-2030)

10.4.5.  North Africa

10.4.5.1.      Market Revenue and Forecast, by Product (2017-2030)

10.4.5.2.      Market Revenue and Forecast, by Application (2017-2030)

10.4.5.3.      Market Revenue and Forecast, by Raw Material (2017-2030)

10.4.6.  South Africa

10.4.6.1.      Market Revenue and Forecast, by Product (2017-2030)

10.4.6.2.      Market Revenue and Forecast, by Application (2017-2030)

10.4.6.3.      Market Revenue and Forecast, by Raw Material (2017-2030)

10.4.7.  Rest of MEA

10.4.7.1.      Market Revenue and Forecast, by Product (2017-2030)

10.4.7.2.      Market Revenue and Forecast, by Application (2017-2030)

10.4.7.3.      Market Revenue and Forecast, by Raw Material (2017-2030)

10.5.        Latin America

10.5.1.  Market Revenue and Forecast, by Product (2017-2030)

10.5.2.  Market Revenue and Forecast, by Application (2017-2030)

10.5.3.  Market Revenue and Forecast, by Raw Material (2017-2030)

10.5.4.  Brazil

10.5.4.1.      Market Revenue and Forecast, by Product (2017-2030)

10.5.4.2.      Market Revenue and Forecast, by Application (2017-2030)

10.5.4.3.      Market Revenue and Forecast, by Raw Material (2017-2030)

10.5.5.  Rest of LATAM

10.5.5.1.      Market Revenue and Forecast, by Product (2017-2030)

10.5.5.2.      Market Revenue and Forecast, by Application (2017-2030)

10.5.5.3.      Market Revenue and Forecast, by Raw Material (2017-2030)

Chapter 11.  Company Profiles

11.1.              Medtronic plc

11.1.1.  Company Overview

11.1.2.  Product Offerings

11.1.3.  Financial Performance

11.1.4.  Recent Initiatives

11.2.              Terumo Corporation

11.2.1.  Company Overview

11.2.2.  Product Offerings

11.2.3.  Financial Performance

11.2.4.  Recent Initiatives

11.3.              LeMaitre Vascular, Inc.

11.3.1.  Company Overview

11.3.2.  Product Offerings

11.3.3.  Financial Performance

11.3.4.  Recent Initiatives

11.4.              C.R. Bard; W.L. Gore and Associates, Inc.

11.4.1.  Company Overview

11.4.2.  Product Offerings

11.4.3.  Financial Performance

11.4.4.  Recent Initiatives

11.5.              Cook Medical

11.5.1.  Company Overview

11.5.2.  Product Offerings

11.5.3.  Financial Performance

11.5.4.  Recent Initiatives

11.6.              Shanghai Suokang Medical Implants Co. Ltd.

11.6.1.  Company Overview

11.6.2.  Product Offerings

11.6.3.  Financial Performance

11.6.4.  Recent Initiatives

11.7.              Getinge AB

11.7.1.  Company Overview

11.7.2.  Product Offerings

11.7.3.  Financial Performance

11.7.4.  Recent Initiatives

Chapter 12.  Research Methodology

12.1.              Primary Research

12.2.              Secondary Research

12.3.              Assumptions

Chapter 13.  Appendix

13.1.              About Us

Glossary of Terms

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38538

Contact Us:

Vision Research Reports

Call: +1 9197 992 333

Email: sales@visionresearchreports.com

Related Articles

Back to top button